Cardiovascular Diseases
Conditions
Keywords
Cardiac surgery, Quantra, Viscoelastic testing, Coagulation, QPlus
Brief summary
Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Detailed description
Yavapai Regional Medical Center (YRMC) implemented the Quantra QPlus System to aid in their efforts to effectively reduce the transfusion rate of allogenic blood products and improve outcomes in patients undergoing cardiac surgery. Use of the Quantra to guide decisions related to the use of blood products in cardiac surgery patients began in 2019. In this retrospective study, YRMC evaluated the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Interventions
DIAGNOSTIC_TESTQuantra QPlus System
Coagulation monitoring system
Sponsors
HemoSonics LLC
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pre-Quantra Group: All consecutive patients undergoing cardiac surgical procedures during the period from January 2019 to September 2019 (n=64) * Post-Quantra Group: All consecutive patients undergoing cardiac surgical procedures during the period from May 2020 to April 2021 (n=64)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood product utilization | Intraoperative - during surgery | Units of blood products administered to patient |
| Cost of blood products | Throughout the entire hospital stay, assessed up to 30 days | Total cost of blood products administered to patient |
Countries
United States
Outcome results
None listed